United States · Markets & Finance · The Motley Fool

Eli Lilly's weight loss drug business

Published by The Motley Fool · United States 10 h ago

And this spring, Lilly won regulatory approval for Foundayo. All three are part of a class of drugs known as GLP-1. These products interact with hormonal pathways involved in…

Read the full article on The Motley Fool Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Business Insider

My 16-year-old still has a 9 p.m. bedtime. It's great for our whole family.

Benzinga

Artificial Intelligence Stocks Under $10

Fortune

‘A Republic, if you can keep it’: We served presidents from both parties and have never been so concerned about election security

CNBC

Berkshire buys more Lennar shares, but pace of purchases slows

Quartz

Good schools come with a hefty homebuyer's premium in these 10 U.S. cities

Forbes